SCHEDULE 13G: Investment Group Discloses 5.1% Passive Stake in Athira Pharma

Steven Michael Oliveira and affiliated entities Nemean Asset Management, LLC, South Ocean Capital Management LLC, and South Ocean Capital LLC have disclosed a combined passive beneficial ownership of 5.109% in Athira Pharma, Inc.'s common stock.

Summary

• Steven Michael Oliveira and affiliated entities Nemean Asset Management, LLC, South Ocean Capital Management LLC, and South Ocean Capital LLC have filed a Schedule 13G with the SEC.
• The filing discloses a collective passive beneficial ownership of 1,994,649 shares of Athira Pharma, Inc.'s common stock.
• This aggregate ownership represents 5.109% of Athira Pharma, Inc.'s outstanding common stock.
• The reporting persons certify that the shares were acquired for investment purposes and not with the intent to change or influence the control of the issuer.
• The event requiring this filing occurred on April 14, 2025.

Sentiment

Score: 6

Explanation: The filing indicates a new or updated significant passive ownership stake by an investment group, which can be viewed as a neutral to slightly positive signal of investor interest in Athira Pharma, Inc.

Positives

• The disclosure of a significant passive stake by an investment group, led by Steven Michael Oliveira, may signal a vote of confidence in Athira Pharma, Inc. from these investors.

Stakeholder Impact

• Shareholders: The disclosure provides transparency regarding a significant ownership stake by an investment group, potentially influencing market perception and trading activity.

Key Dates

Keywords

Athira Pharma Inc., Common Stock, Schedule 13G, Beneficial Ownership, Steven Michael Oliveira, Nemean Asset Management, South Ocean Capital Management, South Ocean Capital, Passive Investment, SEC Filing, Institutional Investor